Autopsy report · NCT00412295

Evaluation of Alcon Ladarvision Wavefront-Guided PRK

“Lack of resources and not because of any concern with the safety or effectiveness of the procedures studied.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Walter Reed Army Medical Center

Sponsor type

US federal agency

Conditions

Myopia

Interventions

Alcon Ladarvision (Wavefront-guided PRK)

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
  “Lack of Efficacy, no safety concern.” (70% match in meaning)
• Pilot Study: Effect of Dexamethasone vs Vicodin in Reducing Post-operative Pain
  “Inadequate resources to start the study at this site.” (69% match in meaning)
• Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors
  “Not related to safety concerns or lack of efficacy” (69% match in meaning)
• A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002)
  “This study was terminated due to lack of clinical activity and not due to safety reasons.” (66% match in meaning)
• Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
  “Due to a lack of safety and efficacy.” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.